Trial Comparing High Versus Standard Dose Oseltamivir in Severe Influenza Infection in ICU
Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Primary Objectives:
The primary objective of the trial is to compare the antiviral efficacy of a 10 day course of
standard (75 mg bid) and high-dose (225 mg bid) oseltamivir (or equivalent doses in
mild-moderate renal failure) in the treatment of severe influenza infections.
The hypothesis is that high dose oseltamivir will increase the proportion of patients with
negative reverse transcriptase (RT)-PCR detection of influenza viral RNA (and viral culture,
at selected sites) at Day 5 post-treatment.
An important secondary objective of the trial, which reflects the main clinical objective, is
to determine the difference in the numbers of ventilator days between the standard-dose and
high-dose groups